Maintenance Neoral Monotherapy Compared to Bitherapy in Renal Transplantation

NCT00461825 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

207

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Cyclosporin A: C0: 75-125ng/ml-dose adapted in the 3 groups
DRUG: Group A: CsA + Azathioprine(1 to 2 mg/kg/day)
DRUG: Group B: CsA + CellCept(500 mg x 2/day)
DRUG: Group C: CsAm

Sponsor

Poitiers University Hospital